Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 28Neoplasms by Site 2Neoplasms 2Neoplasm Metastasis 2Breast Diseases 2Advanced Breast Cancer 2Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Inflammatory Breast Neoplasms 1Hormone-receptor-positive Breast Cancer 1Highly Endocrine Responsive Operable Breast Cancer 1Fatigue 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Tablets 1Letrozole 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Highly Endocrine Responsive Operable Breast Cancer × Gonadotropin-Releasing Hormone × Breast × Clear all
NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Guangdong Provincial People's Hospital

Phase 2 Completed
46 enrolled
Breast

Highly Endocrine Responsive Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡